DK19971/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1993	1
1994	1
1997	1
1998	2
1999	1
2000	2
2001	1
2002	1
2003	1
2004	2
2005	1
2006	1
2007	1
2008	1
2009	2
2010	1
2011	1
2012	1
2013	1
2014	1
2015	1
2016	1
2024	0

1

Merkley ED, Metz TO, Smith RD, Baynes JW, Frizzell N. Merkley ED, et al. Mass Spectrom Rev. 2014 Mar-Apr;33(2):98-109. doi: 10.1002/mas.21382. Epub 2013 Sep 30. Mass Spectrom Rev. 2014. PMID: 24115015 Free PMC article. Review.

2

Succination of proteins in diabetes.

Frizzell N, Lima M, Baynes JW. Frizzell N, et al. Free Radic Res. 2011 Jan;45(1):101-9. doi: 10.3109/10715762.2010.524643. Epub 2010 Oct 22. Free Radic Res. 2011. PMID: 20964553 Review.

3

Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.

Stitt AW, Frizzell N, Thorpe SR. Stitt AW, et al. Curr Pharm Des. 2004;10(27):3349-60. doi: 10.2174/1381612043383124. Curr Pharm Des. 2004. PMID: 15544520 Review.

4

Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.

Nagai R, Murray DB, Metz TO, Baynes JW. Nagai R, et al. Diabetes. 2012 Mar;61(3):549-59. doi: 10.2337/db11-1120. Diabetes. 2012. PMID: 22354928 Free PMC article. Review.

5

A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. Zhang Q, et al. J Proteome Res. 2009 Feb;8(2):754-69. doi: 10.1021/pr800858h. J Proteome Res. 2009. PMID: 19093874 Free PMC article. Review.

6

Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo.

Requena JR, Ahmed MU, Fountain CW, Degenhardt TP, Reddy S, Perez C, Lyons TJ, Jenkins AJ, Baynes JW, Thorpe SR. Requena JR, et al. J Biol Chem. 1997 Jul 11;272(28):17473-9. doi: 10.1074/jbc.272.28.17473. J Biol Chem. 1997. PMID: 9211892 Free article.

7

Autoimmune response to advanced glycosylation end-products of human LDL.

Virella G, Thorpe SR, Alderson NL, Stephan EM, Atchley D, Wagner F, Lopes-Virella MF; DCCT/EDIC Research Group. Virella G, et al. J Lipid Res. 2003 Mar;44(3):487-93. doi: 10.1194/jlr.M200370-JLR200. Epub 2002 Dec 1. J Lipid Res. 2003. PMID: 12562876 Free article.

8

Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.

Virella G, Koskinen S, Krings G, Onorato JM, Thorpe SR, Lopes-Virella M. Virella G, et al. Clin Immunol. 2000 May;95(2):135-44. doi: 10.1006/clim.2000.4857. Clin Immunol. 2000. PMID: 10779407

9

Glycation impairs high-density lipoprotein function.

Hedrick CC, Thorpe SR, Fu MX, Harper CM, Yoo J, Kim SM, Wong H, Peters AL. Hedrick CC, et al. Diabetologia. 2000 Mar;43(3):312-20. doi: 10.1007/s001250050049. Diabetologia. 2000. PMID: 10768092

10

Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.

Alderson NL, Chachich ME, Frizzell N, Canning P, Metz TO, Januszewski AS, Youssef NN, Stitt AW, Baynes JW, Thorpe SR. Alderson NL, et al. Diabetologia. 2004 Aug;47(8):1385-95. doi: 10.1007/s00125-004-1474-8. Epub 2004 Jul 28. Diabetologia. 2004. PMID: 15309289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year